PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $80,000 | +321.1% | 803,200 | +1429.9% | 0.00% | – |
| Q2 2016 | $19,000 | +137.5% | 52,500 | +159.9% | 0.00% | – |
| Q1 2016 | $8,000 | -11.1% | 20,200 | +23.9% | 0.00% | – |
| Q3 2015 | $9,000 | -75.0% | 16,300 | -75.3% | 0.00% | – |
| Q2 2015 | $36,000 | -43.8% | 66,100 | -16.3% | 0.00% | – |
| Q1 2015 | $64,000 | +326.7% | 79,000 | +311.5% | 0.00% | – |
| Q4 2014 | $15,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $6,000 | 0.00% |
| LEE DANNER & BASS INC | 50,000 | $3,000 | 0.00% |
| Ancora Advisors LLC | 14,650 | $1,000 | 0.00% |
| Diversified Trust Co | 50,000 | $3,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 57,659 | $3,000 | 0.00% |
| ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |